Pharmacokinetic study of the phase III, randomized, double-blind, multicenter trial (TRIBUTE) of paclitaxel and carboplatin combined with erlotinib or placebo in patients with advanced Non-small Cell Lung Cancer (NSCLC)
Hai T. Tran; Ralph G. Zinner; George R. Blumenschein; Yun W. Oh; Vassiliki A. Papadimitrakopoulou; Edward S. Kim; Charles Lu; Mubashira Malik; Bert L. Lum; Roy S. Herbst
- 作者Hai T. Tran; Ralph G. Zinner; George R. Blumenschein; Yun W. Oh; Vassiliki A. Papadimitrakopoulou; Edward S. Kim; Charles Lu; Mubashira Malik; Bert L. Lum; Roy S. Herbst
- 卷第29卷
- 期第3期
- 印刷ISSN0167-6997
- 电子ISSN1573-0646
- 文件大小155.86KB
- 发表时间2011-06
- DOI10.1007/s10637-009-9380-z
- 页码499-505